1ml of DTT in liquid phase, in PET tube with capture cap, in bulk Recall
1ml of DTT in liquid phase, in PET tube with capture cap, in bulk
FDA recall Class II
Ongoing
FDA lists this Class II recall for 1ml of DTT in liquid phase, in PET tube with capture cap, in bulk. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0943-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Oct 29, 2025
- FDA report date
- Dec 24, 2025
- Quantity in commerce
- 122,850 units US
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
1ml of DTT in liquid phase, in PET tube with capture cap, in bulk
The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.
Search FDA identifier text
Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.
This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.
FDA code information
UDI:0U020N.A - (01)18053326005043
Why was this product recalled?
Treatment reagent functionality in respiratory specimens fluidification cannot be guaranteed.
What actions did Copan Italia take?
On October 29, 2025, Copan initiated a Urgent: Medical Device Recall Notification via Email to affected consignees Copan ask consignees to take the following actions: 1. Further distribution or use of the remaining product must stop immediately: trace and dispose of all affected products. 2. This notice should be passed on to all those who need to be aware within your organization. 3. Ensure that the same obligations (communication to end users and related evaluation activities) are guaranteed by any additional Customer. In particular, if you have further distributed the devices, please provide those Customers a copy of the recall notification and response form. 4. Confirm you have read and understood the recall instructions provided in the letter, in writing. If you have any questions, call Chief Operating Officer, at 030-2687211.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0943-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology